Officers

Professor Krishnakumar Madhavan is an internationally recognised leader in liver and pancreatic surgery and organ transplantation, with a distinguished career spanning more than four decades across Asia and the United Kingdom. He earned his MBBS from the University of Poona in 1979, followed by an MS in General Surgery from the Postgraduate Institute of Medical Education and Research, Chandigarh, in 1981. He was awarded the Fellowship of the Royal College of Surgeons of Edinburgh (FRCS) in 1989. Professor Madhavan currently serves as Professor Emeritus at the National University of Singapore. He is a Past President of the Asia-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA) and a current elected member of the Council of the Royal College of Surgeons of Edinburgh. His previous leadership roles include Head of the Department of Surgery at both the National University Health System and the National University of Singapore, Director of the Singapore National Liver Transplant Programme, and Co-Director of the National University Centre for Organ Transplantation. He also served as a Consultant Surgeon with the Lothian NHS Trust at the Royal Infirmary of Edinburgh from 1996 to 2007. His research interests focus on hepatocellular carcinoma, particularly its genomics, biomarkers and treatment modalities, as well as liver transplantation techniques, portal hypertension, and the management of acute and chronic pancreatitis. In recognition of his clinical and academic excellence, Professor Madhavan has received numerous honours, including the NUHS Mochtar Riady Pinnacle Master Clinician Award in 2015 and the NUHS Distinguished Senior Clinician Award in 2018. In 2025, he was awarded the A-PHPBA Distinguished Service Award. Professor Madhavan will assume the Presidency of the International Hepato-Pancreato-Biliary Association (IHPBA) for the 2026–2028 term.

Rebecca M. Minter, M.D., M.B.A., is the A.R. Curreri Professor and Chair of the Department of Surgery at the University of Wisconsin School of Medicine and Public Health. Previously, Dr. Minter held successive leadership roles at the University of Texas Southwestern and the University of Michigan, serving as Chief of the Hepatopancreatobiliary Section/Division at both institutions. Dr. Minter's clinical practice is in the areas of pancreatobiliary and gastrointestinal surgery. She has a particular interest in the management and treatment of benign and neoplastic diseases of the pancreas. Dr. Minter is recognized as a clinical leader in her field and is a past President of the Americas Hepatopancreatobiliary Association and is a past Diversity and Inclusion Officer and current President-Elect of the International Hepatopancreatobiliary Association. Dr. Minter's research efforts focus on surgical education, specifically the development of training frameworks which explicitly define progressive entrustment and the development of autonomy. Dr. Minter holds national leadership positions in multiple societies in recognition of her work in the field of surgical education and academic surgery. She is a past President of the Society of University Surgeons and the Fellowship Council, as well as a past Chair of the American Board of Surgery Board of Directors.

Professor Adam served as Head of the Hepato-Biliary Centre at Paul Brousse Hospital and as Medical Director of the Department of Digestive and Hepato-Pancreato-Biliary Diseases, encompassing nine surgical units across four hospitals within the Assistance Publique–Hôpitaux de Paris (AP-HP), until 2024. Since 1994, he has held the position of Professor of Surgery at the Faculty of Medicine of Paris-Saclay University and currently serves as Emeritus Professor. His principal clinical and research interests encompass surgery of the liver, biliary tract and pancreas, as well as liver transplantation. He has a particular interest in the management of primary and secondary liver tumours, especially through multidisciplinary approaches combining chemotherapy and surgery. Professor Adam leads the Paris-Saclay University research team “Chronotherapy, Cancer and Transplantation, “which focuses on circadian rhythms, chrono medicine, liver cancers, and the optimisation of liver function recovery through machine perfusion in liver transplantation. He is also General Manager of the European Liver Transplant Registry (ELTR) and Director of LiverMetSurvey, which he founded in 2005. The registry has collected data on more than 35,000 patients undergoing surgery for colorectal liver metastases. Professor Adam is President of the International Hepato-Pancreato-Biliary Association (IHPBA). He has contributed more than 1,000 scientific communications at international congresses and delivered over 800 invited lectures at meetings worldwide. He has authored more than 650 peer-reviewed publications and has a PubMed H-index of 137, with more than 80,000 citations to date.

Shailesh V. Shrikhande is the Chief Executive of Tata Cancer Care Foundation (TCCF), Director of GI and HPB Cancer Surgery at Gleneagles Hospital, Parel, Mumbai, and a Consultant Surgeon at Breach Candy Hospital and Shrikhande Clinic, Mumbai, India. He is also the Officer on Special Duty at Tata Memorial Centre. Previously, he was Head of GI and HPB Surgery (2010-2025) and Deputy Director of Tata Memorial Hospital (2018-2025), Mumbai. He was ranked first in the Master of Surgery examinations of Mumbai University in 1997 and later received specialist training in Pancreatic Research and Pancreatic Surgery at the University of Bern, Switzerland and the University of Heidelberg, Germany. He was the first Asian to receive the Kenneth Warren Fellowship of the International Hepato-Pancreato-Biliary Association (IHPBA) in 2005. He earned his Doctor of Medicine (magna cum laude) by the University of Heidelberg for his original clinical and basic research on chronic pancreatitis and pancreatic cancer in 2006. He has delivered over 600 lectures and orations all over the world. Apart from having published over 370 clinical and basic science research papers in leading peer-reviewed journals (including a series of 1200 Whipple Resections), Professor Shrikhande has also given 65 live operative masterclass demonstrations on pancreatic, gastric, gall bladder and colorectal cancer across India and abroad. He has contributed over 75 book chapters and is the Chief Editor of the books “Surgery of Pancreatic tumours” (2007) and “Pancreatic Cancer: Current Understanding” (2011), ‘Modern Gastrointestinal Oncology (2015) and Pancreas (2023). His h-index (perhaps the best indicator of true scientific merit) stands at 67; the highest amongst his peers across India and amongst the best in the world. He has been an invited Visiting Professor to 12 prestigious Universities in the USA, Europe and Japan. He is Adjunct Professor in Surgical Oncology in KMC, Manipal and in KLE University Hospital, Belgaum. He was the Chairman of the Indian Council Medical Research (ICMR) committee for developing guidelines for the management of Pancreatic and Gastric Cancer in India. He is the associate editor of Langenbecks Archives of Surgery and serves on the editorial boards of leading international journals of GI and HPB surgery. He is the Past President of the Indian Chapter of IHPBA. He is the Immediate Past President of the APHPBA (the youngest ever) and the Secretary-General Elect of the IHPBA (The first Indian ever). In recognition of his work on pancreatic cancer and digestive cancer surgery in India, he was awarded an Honorary Fellowship from the Royal College of Surgeons of England in 2014 (FRCS – Ad Eundem) and the Honorary Fellowship (ad hominem) of the Royal College of Surgeons of Edinburgh in March 2025. In 2021, he became only the second Indian in the 144-year history of the American Surgical Association (ASA) to be conferred the Honorary Fellowship of ASA for “unusually noteworthy contributions to surgery of long-lasting value and worthy of the highest International Recognition”. He is the only Indian invited to serve as a board member of the International Study Group of Pancreatic Surgery (ISGPS) since 2023. Recently, he was conferred Honorary Fellowship of American College of Surgeons (FACS) in San Francisco at the Annual ACS Congress in October 2024. He is thus the only Indian Surgeon to be conferred by honorary fellowships of the four leading surgical societies in the world. Stanford University published a list of world’s best contributing researchers in the PLOS One journal in November 2021, 2022, 2023 and even in 2024. Professor Shrikhande is ranked amongst the top 2% (amongst >55,000 researchers) worldwide. In 2021, the Honourable Governor of Maharashtra, His Excellency Shri Bhagat Singh Koshyari, honoured him with “Excellence in Cancer Care” award for his world recognized work on Digestive and Pancreatic Cancer Surgery and his dedication towards building a futuristic cancer centre to serve the needs of the nation for the next 50 years. In his previous administrative capacity as a Deputy Director and now as Officer on Special Duty at Tata Memorial, he is currently spearheading the Tata Memorial Centre’s expansion plan which shall comprise of a 550-bed state of the art hospital (Platinum Jubilee Block) and even a Dharamshala designed exclusively for poor patients in Mumbai. Thanks to his relentless efforts and leadership, the hospital has already constructed and commissioned a 15 floor Doctors and Nurses Hostel. Furthermore, he secured 100 flats in 2022 from Maharashtra Housing and Area Development Authority (MHADA) to mitigate the suffering of exclusively poor patients and their relatives who seek treatment at Tata Memorial Centre from remote corners of India. Prof. Shrikhande also provides technical advisory support to charitable institutions for establishing cancer centers, including the Dharmaveer Anand Dighe Cancer Hospital in Thane (in collaboration with the Thane Municipal Corporation and the JITO Trust), Goa Medical College, and Guruji Rugnalay in Nashik. In his current role of Chief Executive of TCCF, he spearheads the development of cancer care across India in keeping with the objectives of affordable, high quality cancer care that is available and accessible in far flung corners of India.

Dr. Pawlik received his undergraduate degree from Georgetown University and his medical degree from Tufts University School of Medicine. Dr. Pawlik completed surgical training at the University of Michigan Hospital and spent two years at the Massachusetts General Hospital as a surgical oncology research fellow. He then went on for advanced training in surgical oncology at The University of Texas M. D. Anderson Cancer Center in Houston. Dr. Pawlik’s main clinical interests include alimentary tract surgery, with a special interest in hepatic, pancreatic and biliary diseases. Dr. Pawlik also has an interest in medical ethics and completed a fellowship in medical ethics at the Harvard School of Public Health, as well as a Masters in Theology from Harvard Divinity School in Boston. In addition, Dr. Pawlik was the recipient of a Clinical and Translational Science Award (CTSA) KL2 Research Scholar Award and received a PhD from the Johns Hopkins Bloomberg School of Public Health in Clinical Investigations. Dr. Pawlik also received his Executive MBA Program from The Ohio State University Fisher Business School and has participated in leadership courses at the Northwestern Kellogg School of Management. Dr. Pawlik took his first faculty appointment at Johns Hopkins in 2005, where he was Professor of Surgery and Oncology, as well as the John L. Cameron Chair of Alimentary Tract Diseases and the Chief of the Division of Surgical Oncology until 2016. Dr. Pawlik currently is the Chair of Surgery at The Ohio State University Wexner Medical Center where he holds The Urban Meyer III and Shelley Meyer Chair for Cancer Research. Under his leadership, the Department of Surgery has recruited over 90 new faculty members, is ranked #9 for NIH funding, and has a top 10 ranked surgical residency program. Dr. Pawlik is also past Treasurer / Secretary of The Ohio State University Practice Plan. Dr. Pawlik has given over 675 invited talks both nationally and internationally in 40+ different countries. Dr. Pawlik has published over 2,300 articles and 130 book chapters, in addition to editing 17 surgical textbooks; he is a co-I on an NIH R01 investigating IPMNs. His research has been cited over 110,000 times with an H-index of 163, i10 index of 1,321, and an iCite weighted RCR of over 3367. Dr. Pawlik serves on multiple editorial boards and is Editor-in-Chief of Journal of Gastrointestinal Surgery, Deputy Editor of JAMA Surgery, as well as an Associate Editor for Annals of Surgical Oncology. Dr. Pawlik has served on the executive council of several of the premier surgical associations in the United States. Dr. Pawlik is a member of multiple surgical societies including the American Surgical Association, Society of Surgical Oncology, Society of Surgery of the Alimentary Tract, Halsted Society, and Society of Clinical Surgery. Dr. Pawlik is a past-President of the Association for Academic Surgery, past-President of the Americas Hepato-Pancreato-Biliary Association, co-President of the Surgical Biology II Club, as well as current President of the Association for Academic Surgery Foundation. Dr. Pawlik’s international contributions have been recognized through his multiple honorary memberships in the Royal Australasian College of Surgeons, Royal College of Surgeons of Edinburgh, University of Athens, Brazilian Society of Surgical Oncology, Mexican Association for Surgery of the Alimentary Tract, Argentinian Hospital de Clinicas, Portugal Surgical Society, Colombian Surgical Association, Italian Surgical Society, as well as the Society of General Surgeons of Perú and the Peruvian International Hepato-Pancreatobiliary Association. Dr. Pawlik is a Member of the Academy of Master Educators in the ACS. Dr. Pawlik’s research focuses on determinations of factors associated with prognosis and staging of gastrointestinal cancers, as well as the economics of cancer care. He also studies patient/physician communication and patient engagement, as well as patient perception of cancer-care goals and the impact of social determinants of health. Dr. Pawlik has consistently been recognized by Castle Connolly as one of America’s “Top Docs.”

Dr. Alice C. Wei is an Attending Surgeon at Memorial Sloan-Kettering Cancer Center (MSKCC) and Professor of Surgery at Weill Cornell Medicine in New York. She serves as Co-Director of Surgical Initiatives at the David M. Rubenstein Center for Pancreatic Cancer Research at MSKCC and Program Director of the MSKCC Complex General Surgical Oncology Fellowship. Dr. Wei earned her medical degree at McGill University in Montreal and completed her General Surgery residency and Hepatobiliary/GI Transplantation Fellowship at the University of Toronto, where she also held her first faculty appointment at Toronto General Hospital, Canada. Dr. Wei's clinical practice focuses on HPB surgical oncology, with expertise in robotic liver and pancreas procedures. Her research spans two areas: clinical trials on multimodality therapy for pancreatic cancer with vascular involvement, and health services research on implementing quality improvement strategies in cancer surgery. She also brings expertise in health policy, having served as Lead for Quality and Knowledge Transfer for the Surgical Oncology Program at Cancer Care Ontario (2014–2018), advising the Ontario government on system-level cancer surgery policy. Dr. Wei has held major leadership roles in Canadian and American surgical societies, including AHPBA Specialty Governor at the American College of Surgeons, President of the Ontario Association of General Surgeons, and Board Member of the Canadian Association of General Surgeons.

Ajith Siriwardena MD FRCS, studied medicine at the University of Manchester and then trained in General and Hepatobiliary Surgery in Manchester, Edinburgh, Richmond USA and Paris. I moved to my current position as Consultant Surgeon at the Manchester Royal Infirmary in 1999 and was appointed Professor of Hepatobiliary Surgery at the University of Manchester in 2008. In 2007 I received the prestigious “Silver Scalpel” award as the best surgical trainer in the UK. My clinical practice is in Hepato-pancreato-biliary oncological surgery with a focus on liver and pancreas cancer surgery. I was President of the Pancreatic Society of Gt.Britain and Ireland in 2016 and President of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA) from 2021 to 2023. I am currently a member of Council of the International Hepato-Pancreato-Biliary Association (IHPBA) and serve on the Board of Directors of the IHPBA Foundation. I am leading the IHPBA Legacy project to develop meaningful guidelines for the management of patients with hepatocellular cancer in resource-sensitive healthcare systems and the IHPBA Bile duct injury study group. I am the lead for the international study of IRE in patients with colorectal liver metastases (LIVERMET-IRE) and the parallel study for patients with HCC treated by IRE (LIVERHCC-IRE).

Maria B. Majella Doyle, M.D., M.B.A., F.A.C.S., is a Professor of Surgery, Mid-America Transplant and Department of Surgery Distinguished Endowed Chair in Abdominal Transplant, and Director of adult and pediatric Liver Transplant in the Division of Transplantation, and Executive Vice-Chair of the Department of Surgery at Washington University. She also has a keen interest in Faculty development and Chairs the Faculty Promotions committee. Dr. Majella Doyle received her Bachelor of Arts Degree at Trinity College in Dublin Ireland before completion of medical school at the Royal College of Surgeons in Ireland. She then completed her surgical residency in the Irish General Surgical Training Program before completing a Research Fellowship in the Department of Academic Surgery at Cork University in Cork, Ireland. She completed a Clinical Fellowship in Abdominal Organ Transplant and HPB Surgery at Washington University School of Medicine in St. Louis, Missouri and was subsequently recruited as a member of the Abdominal Organ Transplant and Hepatobiliary Surgery team. Her interests at the university are focused on adult and pediatric hepatobiliary and pancreatic surgery as well as liver and kidney transplant. She focuses her clinical research interests on clinical outcomes, transplant oncology, liver transplantation, and donor management. Dr. Doyle has played an active role in US national transplant surgery and HPB organizations. She is the past president of the Western Surgical Association and Americas Hepatopancreatobiliary Association (AHPBA) and past councilor of the American Society of Transplant Surgery (ASTS). She has been a mentor for many surgical trainees is on the executive council of the Fellowship Council governing HPB fellowship training in the US and in 2025 received the Francis Moore Excellence in Mentorship in Transplantation Surgery Award from the American Society of Transplant Surgeons (ASTS).

Dr. Julie Hallet is an Associate Professor of Surgery at the University of Toronto and a Surgical Oncologist with a clinical practice devoted to hepato-biliary, pancreatic, and upper gastrointestinal malignancies at the Odette Cancer Centre - Sunnybrook Health Sciences Centre. Her practice further focuses on neuroendocrine tumors as part of the Susan Leslie Clinic for Neuroendocrine Tumors. She completed general surgery residency and MSc in clinical epidemiology at Université Laval in Québec City, followed by a surgical oncology and hepato-pancreato-biliary fellowship at the University of Toronto, and additional training at the Institut de recherche contre les cancers de l’appareil digestif (IRCAD) in Strasbourg, France. She holds the Canada Research Chair in Patient-Centred & Quality Cancer Surgery. Her program in health services research aims to improve the fidelity of care delivery in cancer surgery through access to quality care, high-performing team care models, and risk communication support, with a commitment to patient-centred research and equity. To support her research, she has received over $14 millions in peer-reviewed operating grants. This work has led to over 300 peer-reviewed publications. Dr. Hallet holds leadership roles in National and International societies. Among those roles, she serves as Board member for the Society of Surgical Oncology and the North American Neuroendocrine Tumors Society, Chair of the Inclusive Excellence Committee of the International Hepato-Pancreato-Biliary Association, and Immediate Past President of the Society of Surgical Ergonomics. She is co-founder of and coordinates the Collaborative of sUrgical Teams for Neuroendocrine Tumors (CUTNETs), an international group that aims to leverage collective expertise and resources to improve the surgical care and outcomes of patients with NETs. She is also Section Editor for the Annals of Surgical Oncology and part of the Editorial Board of HPB and BJS.

Dr Sanket (Sunny) Srinivasa is a Consultant Hepato-Pancreato-Biliary (HPB) Surgeon at North Shore Hospital, Auckland, and a Senior Lecturer in Surgery at the University of Auckland. He is internationally recognised for his expertise in minimally invasive liver and pancreatic surgery, with particular interests in robotic HPB surgery, surgical oncology, and innovation in surgical education. Following specialist surgical training in New Zealand, Dr Srinivasa completed advanced HPB fellowships at the Royal Infirmary of Edinburgh in the United Kingdom and Washington University in St Louis, USA—one of the world's leading HPB and surgical oncology centres. He is New Zealand's only HPB surgeon with formal robotic fellowship training and has played a leading role in establishing robotic HPB surgery within the region, including New Zealand's first robotic pancreaticoduodenectomy and the development of minimally invasive major liver and pancreatic resection programs. An accomplished surgeon-scientist, Dr Srinivasa leads an active clinical research programme focused on minimally invasive surgery, HPB oncology, robotic surgery, surgical education, and patient-centred outcomes. He has authored more than 100 peer-reviewed publications and book chapters, supervises higher-degree research students, and serves as a reviewer for several leading international surgical journals. Dr Srinivasa also holds numerous national and international leadership positions, including Oceania Faculty Member of the Global Robotic HPB Expert Committee, Clinical Lead for Robotic General Surgery in New Zealand, Executive Member of the New Zealand Association of General Surgeons, and is the incoming President (2026-2028) of the International Hepato-Pancreato-Biliary Association (IHPBA) Early Career Group. He is married with two children and is a student of jiujitsu in his spare time.